The 3rd QbD Biopharmaceutical Quality Science Conference

[Pharmaceutical Network Conference Forum] On May 28, 2021, the State Food and Drug Administration issued the "Administrative Measures for Drug Inspection (Trial)", GMP/GSP standards + administrative licensing, the threshold has been raised, and the frequency of unannounced inspections for drug production and operation is related to The intensity is also increasing, and the main responsibility of the "marketing licensee" is gradually strengthened, which shows the determination of the state for drug supervision
.

The core of strict supervision is to urge pharmaceutical companies to establish an attitude and awareness of being responsible for their own quality.
Effective supervision and corporate consciousness are indispensable.
However, how to cooperate with each other to improve the quality of drugs still has a long way to go
.

In recent years, under the factors of frequent international turmoil, continuous involution, and the implementation of CDE's new anti-tumor policy, it can be described as internal and external troubles, wind and rain, for innovative pharmaceutical companies in the pain period, it seems that internationalization is the other side of hope
.

The time window is fleeting, and the long-term growth of innovative drugs requires more courage and perseverance
.

"Quality is the life of an enterprise", and the level of drug quality determines its clinical performance
.

2022 is the first year of the internationalization of innovative drugs.
When innovation goes overseas and becomes a strong voice in medicine, quality personnel and pharmacy registrants need to cultivate their internal skills to meet the challenges
.

In this context, how local pharmaceutical companies can go overseas on the premise of adhering to drug quality standards is the focus of this conference
.

The 2022 3rd QbD Biopharmaceutical Quality Science Conference sponsored by BIOGO will be held in Beijing on May 13-14! Four parallel forums were set up this time, and 1000+ industry colleagues and 70+ big coffees were invited to participate in the meeting to jointly explore and discuss, adhere to the high quality of domestic enterprises, improve the level of quality management, and walk with international standards
.

Forum 3: Tickets for the Global Drug Policy and Regulation Forum - including all forums of the conference Price: 1,600 yuan per person including admission tickets for all forums of the two-day conference Two-day ultra-luxurious buffet lunch + conference coffee break Conference materials + guest authorization ppt 2022 Biopharmaceutical Editor One selected compilation book (market price: 168 yuan/book) Group purchase discount for reserved seats in the front row: 3 or more people register, the registration fee is 1400 yuan/person, 6 people or more, the registration fee is 1200 yuan/person (April Valid before the 16th) Note: The forum is limited to 200 delegates, while stocks last! The highlights of the conference should not be missed 1.
Thousands of people conference focusing on the field of biological drug quality International drug registration regulations and quality requirements, understand the regulatory culture of various countries, and formulate global strategies 4.
Guests such as pharmaceutical giants, innovative pharmaceutical companies, and regulatory authorities 5.
☞ Yu Lei, Institute of Biological Products Control, Recombinant Drugs, Institute of Biological Products ☞ Huo Yan, former Director of General Toxicology Department, Institute of Internal Medicine ☞ Yang Huan, Director of Clinical Research Center, Peking University School of Medicine Recombinant Drug Room of the institute ☞ Wang Jiang, CSO of Hua Ke Rui Biotechnology ☞ Zhang Boyan, Deputy General Manager and Chief Scientist of Beijing Tianguangshi ☞ Xu Shengchanghui, Chief Technology Officer of Big Gene ☞ Zhang Yi, Director of Biological Cell Therapy Center, First Affiliated Hospital of Zhengzhou University ☞ Shi Ruina, Beijing Yimiao Head of China Quality ☞ Sun Liying, Chief Scientist of Hai Jinge ☞ Lin Junjiahe, Vice President of Biology ☞ Wang Hongyu, Chief Quality Officer of Saifen Technology ☞ Liu Shuangsheng, President of Yiming Cell Quality More important guests will be announced continuously.
.
.
.
.
.
The booth for business cooperation is eagerly scheduled.
.
.
The 3rd QbD Biopharmaceutical Quality Science Conference in 2022 will provide you with cost-effective and customized sponsorship plans.
If you want to have a new product promotion plan in 2022, or you want to If you are close to the decision makers of pharmaceutical companies, you can't miss our conference! For customized exhibition/conference report/conference registration/media cooperation, please contact: Contact person: Abby See below for relevant data download [Note: QbD, enter the quality conference group chat to get more conference information] Past highlights